Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia.
Xu BY, Jin K, Wu HS, Liu XJ, Wang XJ, Sang H, Li KQ, Sun MJ, Meng HQ, Deng HL, Xun ZY, Yang XD, Zhang L, Li GJ, Zhang RL, Cai DF, Liu JH, Zhao GJ, Liu LF, Wang G, Zhao CL, Guo B, Jin SC, Huang LY, Yang FD, Zheng JM, Zhan GL, Fang MS, Meng XJ, Zhang GY, Li HM, Liu XL, Li JH, Wu B, Li HY, Chen JD.
Xu BY, et al.
World J Psychiatry. 2024 Nov 19;14(11):1735-1745. doi: 10.5498/wjp.v14.i11.1735. eCollection 2024 Nov 19.
World J Psychiatry. 2024.
PMID: 39564169
Free PMC article.